Recipharm names 2019 International Environmental Award winner
Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water Science Center in Iowa City, Iowa.
Dana Kolpin’s extensive expertise in source-to-receptor research includes the impact and effects of environmental contaminants which are used in today’s society such as pharmaceuticals and pesticides. Mr. Kolpin has been the lead on two national, multidisciplinary projects for the U.S. Geological Survey’s Toxic Substances Hydrology Program: the Contaminants of Emerging Concern Project (1998-2017) and the Food Resources Project (2018 to present). These projects are dedicated to identifiing new contaminants and sources of contaminants with the ultimate goal of increasing our understanding of the environmental consequences of exposure to the plethora of chemical and microbial contaminants that are present in the environment.
Throughout his more than 30-year career with the USGS, Mr. Kolpin has published over 220 papers and reports on environmental contaminants that have received over 16,400 citations in scientific literature. His paper "Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance" was seminal on the topic of environmental exposures to pharmaceuticals and has become the most heavily cited paper in the history of Environmental Science & Technology. In addition, his research has been highlighted in Discover and Time magazines and he has received the USGS Shoemaker Award for Communication Product Excellence and the U.S. Environmental Protection Agency’s ORD Bronze medal.
Lars Backsell, Chairman of the Board of Recipharm said: “We are delighted to present the 2019 award to Dana Kolpin. His work represents a pioneering approach to exploring the potential effects and risks of contaminants, including pharmaceuticals, on the environment. His research has been both influencial and inspirational for other scientists in this field and has without doubt been essential in building a stronger understanding of the environmental impact of various types of contaminants.”
Mr. Kolpin routinely collaborates with international colleagues to conduct research on environmental contaminants and he is one of the founding organisers of the “Emerging Contaminants” international conference series. He is now actively engaged in the U.S. Geological Survey’s newly formed Food Resources Project.
He said: “I am very honoured to receive this award and thank Recipharm for the recognition of the research that has been conducted by me and my team. It is satisfying to know that our work has inspired others to conduct environmental research on this rapidly evolving topic. Since the start of my career, science has come a long way regarding the understanding of the potential consequences from contaminant exposures, but there more to be understood, particularly when it comes to the effects of chronic exposures to complex mixtures of environmental contaminants. We need to take stock of where we are and what we have learned to better position our future research priorities in both the short and long term.”
The prize ceremony will take place later this year. The date, location and programme will be announced this spring.
Lars Backsell, Recipharm Chairman of the Board, +46 8 602 52 00
Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability, email@example.com, + 46 8 602 52 85
For media enquiries, please contact Lindsay Baldry at ramarketing: firstname.lastname@example.org, + 44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr, Linkedin: /ramarketing
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 7,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s turnover is approximately SEK 7.5 billion. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.
For more information on Recipharm and our services, please visit www.recipharm.com
About Recipharm’s International Environmental Award
Since Recipharm was founded in 1995, our environmental agenda has been a central part of the way we do business. It is our belief that transparency, cooperation and encouragement are necessary if we are to achieve sustainable development. In order to promote this belief, we introduced an international environmental award in 2008 for the best environmental practice or innovation within the pharmacy and health care industries or academia.
For more information visit www.recipharm.com/sustainability/recipharm-international-environmental-award